benzothiazole has been researched along with cytochrome c-t in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lidan, Z; Luoting, Y; Ningyu, W; Tinghong, Y; Xuanhong, S; Xuejiao, S; Yaojie, S; Yong, X; Yongxia, Z; Youzhi, X | 1 |
1 other study(ies) available for benzothiazole and cytochrome c-t
| Article | Year |
|---|---|
A novel benzothiazole derivative YLT322 induces apoptosis via the mitochondrial apoptosis pathway in vitro with anti-tumor activity in solid malignancies.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Benzothiazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytochromes c; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondria; Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Xenograft Model Antitumor Assays | 2013 |